NCT05141825 is a NA clinical trial of proton and carbon ion radiotherapy in Cervical Cancer, sponsored by Shanghai Proton and Heavy Ion Center.

Who is sponsoring NCT05141825?

NCT05141825 is sponsored by Shanghai Proton and Heavy Ion Center.

What drugs are being tested in NCT05141825?

Interventions in NCT05141825: proton and carbon ion radiotherapy.

What condition does NCT05141825 study?

NCT05141825 studies Cervical Cancer.

Is NCT05141825 still recruiting?

NCT05141825 is currently completed. Last updated 2 December 2021.

Last reviewed 2021-12-02 · How we verify

NCT05141825

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Proton and Carbon Ion Radiotherapy for Cervical Cancer

Completed NA Last updated 2 December 2021

What this trial tests

NA trial testing proton and carbon ion radiotherapy in Cervical Cancer in 16 participants. Completed in 31 October 2021.

Timeline

1 January 2016

Primary endpoint
31 October 2021

31 October 2021

Quick facts

Lead sponsor	Shanghai Proton and Heavy Ion Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	16
Start date	1 January 2016
Primary completion	31 October 2021
Estimated completion	31 October 2021

Drugs / interventions tested

proton and carbon ion radiotherapy

Conditions studied

Cervical Cancer — all drugs for Cervical Cancer →

Sponsor

Shanghai Proton and Heavy Ion Center — full company profile →

Who can join

18 and older, female only, with Cervical Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the toxicity and tolerance of proton and carbon ion radiotherapy (PCRT) for cervical cancer.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Combined proton and carbon ion radiotherapy for uterine cervical squamous cell carcinoma: A retrospective analysis
Yu Z, Hong Z, Li P, Wang Z, et al · · 2022 · DOI 10.21203/rs.3.rs-1321735/v1

Verify or expand the search:

Other trials of proton and carbon ion radiotherapy

Trials testing the same drug.

NCT03949933 — Proton and Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer · NA · completed

Other recruiting trials for Cervical Cancer

Currently open trials in the same condition.

NCT07276360 — Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda · Phase 2 · recruiting
NCT05570422 — A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01 · Phase 1 · recruiting
NCT07225530 — Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR) · NA · recruiting
NCT07209917 — Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India · NA · recruiting
NCT07256236 — SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer · Phase 2 · recruiting

Other Shanghai Proton and Heavy Ion Center trials

Trials by the same sponsor.

NCT07135661 — Ultra-Hypofractionated vs. Moderately Hypofractionated Proton Therapy for Early Breast Cancer After Lumpectomy · NA · recruiting
NCT05613452 — Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer · Phase 2 · recruiting
NCT06677879 — A Prospective Cohort Study of Proton and Photon Therapy for Left-sided Breast Cancer. · Phase 2 · recruiting
NCT05878678 — Prospective Study of Particle Radiotherapy for Breast Cancer With Different Arm Position · Phase 2 · unknown
NCT05692661 — A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer · Phase 1 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05141825 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shanghai Proton and Heavy Ion Center
Last refreshed: 2 December 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05141825.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing